Search

everythinglearnresearchcommunity

for

Search:↓

The refined wash test is a reliable way to measure daily hair loss and can tell the difference between different types of hair loss.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Biotin deficiency is not a major cause of Telogen Effluvium hair loss.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

PRP helps skin heal, possibly through special cells called telocytes.

Lipedema is a painful fat disorder in women that's hard to treat, often worsens with hormonal changes, and requires symptom-focused therapies.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

Trichoscopy helps diagnose and monitor hair and scalp problems without needing many biopsies.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

The treatment improved hair thickness, shine, and reduced hair loss effectively.

Nanoparticles may improve caffeine delivery for hair growth, offering a potential alternative to minoxidil for hair loss treatment.

Extracorporeal shock waves significantly improve hair growth in women with female pattern hair loss.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.

RF-based therapies might help treat hair loss.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Zinc levels and lymphocyte counts might be important in heart disease development.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

There's a significant link between the severity of Seborrheic Dermatitis and the pattern of hair loss in people with a family history of hair loss.

The 1565 nm non-ablative fractional laser is more effective and satisfying than 5% minoxidil for treating hair loss.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.